Cabaletta Bio, Inc. (CABA)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch CABA
See up to 3 months of CABA. The 7-day demo opens the 1M and 3M ranges and puts CABA on your watchlist.
Start 7-day demoLatest CABA insider trades
David J. Chang - OfficerOpen-market purchase$20K- Gwendolyn Binder - OfficerOpen-market purchase$25K
About Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. files with the SEC under CIK 0001759138 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
CABA Form 4 activity by transaction type, last 90 days
No Form 4 activity for CABA in the last 90 days.
CABA insider transactions (Form 4)
2922 Form 4 filings on record, the earliest from May 19, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Shawn Tomasello | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
 Mark Simon | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Richard C. Henriques Jr. | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
 Catherine Bollard | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Scott C. Brun | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Arun Das - Officer | Grant or award | Stock Option (Right to Buy) | 175,000 | $0.00 | - | |
| Michael Gerard - Officer | Grant or award | Stock Option (Right to Buy) | 175,000 | $0.00 | - | |
| Gwendolyn Binder - Officer | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| David J. Chang - Officer | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| Steven Nichtberger - Officer | Grant or award | Stock Option (Right to Buy) | 674,000 | $0.00 | - | |
| Anup Marda - Officer | Grant or award | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| David J. Chang - Officer | Open-market purchase | Common Stock | 8,800 | $2.26 | $20K | |
| Gwendolyn Binder - Officer | Open-market purchase | Common Stock | 11,312 | $2.19 | $25K | |
| Shawn Tomasello | Open-market purchase | Common Stock | 22,725 | $2.21 | $50K | |
| Steve Gavel - Officer | Open-market purchase | Common Stock | 22,170 | $2.27 footnote F1 | $50K | |
| ||||||
| Catherine Bollard | Open-market purchase | Common Stock | 4,405 | $2.27 | $10K | |
| Steven Nichtberger - Officer | Open-market purchase | Common Stock | 45,000 | $2.24 footnote F1 | $101K | |
| ||||||
| Mark Simon | Open-market purchase | Common Stock | 11,061 | $2.28 footnote F1 | $25K | |
| ||||||
| Michael Gerard - Officer | Open-market purchase | Common Stock | 6,600 | $2.27 footnote F1 | $15K | |
| ||||||
| Steve Gavel - Officer | Grant or award | Stock Option (Right to Buy) | 275,000 footnote F1 | $0.00 | - | |
| ||||||
| Richard C. Henriques Jr. | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Richard C. Henriques Jr. | Derivative | Stock Option (Right to Buy) | 46,428 | $0.00 | - | |
| Richard C. Henriques Jr. | Grant or award | Stock Option (Right to Buy) | 46,428 | $0.00 | - | |
| Richard C. Henriques Jr. | Derivative | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Richard C. Henriques Jr. | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Richard C. Henriques Jr. | Derivative | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Richard C. Henriques Jr. | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Richard C. Henriques Jr. | Derivative | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Richard C. Henriques Jr. | Grant or award | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
Item 8.01
Item 2.02, 9.01
Item 5.03, 5.07, 9.01
Item 7.01, 8.01, 9.01
CABA insider trading FAQ
What is the latest insider trade for CABA?
Cabaletta Bio, Inc. (CABA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-10. The full record for CABA runs to 22 Form 4 filings, the earliest from 2025-05-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CABA stock?
No insider purchases of CABA were filed in the last 90 days. 8 purchases are on record for this company.
How many insiders are selling CABA stock?
No insider sales of CABA were filed in the last 90 days.
Where can I see CABA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CABA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Shawn Tomasello view on EDGAR
- - Mark Simon view on EDGAR
- - Richard C. Henriques Jr. view on EDGAR
- - Catherine Bollard view on EDGAR
- - Scott C. Brun view on EDGAR
- - Arun Das view on EDGAR
- - Michael Gerard view on EDGAR
- - Gwendolyn Binder view on EDGAR
- - David J. Chang view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CABA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CABA with a 7-day demo
- CABA on your watchlist
- Every CABA Form 4 filing on record
- Up to 3 months of CABA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
